5 facts about access to new medicines
Once a new medicine has been approved by the European Commission, the pharmaceutical companies negotiate with Member States to bring this medicine onto the national market. Disparities in the time it takes for patients to access new medicines in different EU Member States are increasing.
How will the new pharma strategy ensure equal access to new medicines, no matter where patients live?
Read more: https://www.europarl.europa.eu/stoa/e...
Our publications are also available on our EPRS app:
📲 iOS: http://epyoutube.eu/q57W
📲 Android: http://epyoutube.eu/q57X
Watch video 5 facts about access to new medicines online without registration, duration hours minute second in high quality. This video was added by user European Parliamentary Research Service 28 March 2023, don't forget to share it with your friends and acquaintances, it has been viewed on our site 291 once and liked it 9 people.